- Patients with locally recurrent rectal cancer (histologically or cytologically confirmed adenocarcinoma), with a confirmed oncogenic KRAS exon 2, codon 12 or 13 mutations, who are considered suitable for radical resection(R0) (e.g. pelvic exenteration)